Catalyst Wire Dossier Catalyst Wire Dossier

Lisdexamfetamine dimesylate (Vyvanse)

lisdexamfetamine dimesylate · Shire
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Lisdexamfetamine dimesylate (Vyvanse), covering 2017-08-02 to 2017-08-02. Get the full timeline:

Most recent: Clinical Trial Update: Lisdexamfetamine Dimesylate in the Treatment of Adult ADHD With Anxiety Disorder Comorbidity [Phase 4]

See pricing